{"schema_version":"1","generated_at":"2026-10-31T13:13:40.214Z","data_as_of":null,"url":"https://www.findmykol.com/kol/carlos-bachier","json_url":"https://www.findmykol.com/kol/carlos-bachier/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"carlos-bachier","name":"Carlos Bachier","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"city":"San Juan","state":"PR"},"identifiers":{"npi":"1588621031","openalex":"A5026503525"},"summary":"Carlos Bachier is a Hematology physician. OpenAlex indexes 171 publications with 3,093 citations (h-index 26); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":171,"cited_by_count":3093,"h_index":26,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03436862","title":"Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"SCRI Development Innovations, LLC","source_url":"https://clinicaltrials.gov/study/NCT03436862","trial_url":"https://www.findmykol.com/trial/NCT03436862"},{"nct":"NCT02168101","title":"Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"SCRI Development Innovations, LLC","source_url":"https://clinicaltrials.gov/study/NCT02168101","trial_url":"https://www.findmykol.com/trial/NCT02168101"}],"source":"trials"},"payments":{"company_count":36,"program_years":{"first":2021,"last":null},"rows_total":65,"shown":3,"withheld":62,"rows":[{"payer":"Janssen Pharmaceuticals, Inc","program_year":2025,"amount_usd":272.8,"payment_count":12,"source_url":"https://openpaymentsdata.cms.gov/search?query=1588621031"},{"payer":"Rigel Pharmaceuticals, Inc.","program_year":2025,"amount_usd":197.16,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1588621031"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":176.76,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1588621031"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1588621031","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial","year":2025,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(24)02462-0","status":"verified"},{"title":"Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network","year":2024,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2024014171","status":"verified"},{"title":"OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL","year":2024,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2024013254","status":"verified"},{"title":"Dual targeting of CD19 and CD22 with Bicistronic CAR-T cells in Patients with Relapsed/Refractory Large B Cell Lymphoma","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2022018598","status":"verified"},{"title":"Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir","year":2023,"journal":"Clinical Infectious Diseases","source_url":"https://doi.org/10.1093/cid/ciad709","status":"verified"}],"source":"works"},"contact":{"address_1":"HOSPITAL AUXILIO MUTUO","address_2":"AVE JUAN PONCE DE LEON 715","city":"San Juan","state":"PR","zip":"009175032","phone":"787-758-2000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1588621031","source":"identity"},"similar":[{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":62,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-11-06","provider_certified":"2023-11-03","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}